Skip to main content
Fig. 1 | BMC Medicine

Fig. 1

From: Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma

Fig. 1

a Cancer-specific survival (CSS) of clear cell renal cell carcinoma (ccRCC) tumors predicted by the S397-score. Kaplan–Meier curves showing CSS of ccRCC cohort 1 (n = 52). Groups are defined by the cut-off of the S397-score, as determined by conditional inference tree models in Büttner et al. [13]. b Validation of the S397-score in sunitinib-treated ccRCC patients. Kaplan–Meier curves showing progression-free survival predicted by the S397-score in an independent cohort of primary tumors of sunitinib-treated patients (n = 53). Groups are defined by the same cut-off value of the S397-score as in a. HR hazard ratio, CI confidence interval. Detailed information on statistical methods is provided in Additional file 1: Supplementary methods

Back to article page
\